+1 (855) PLE.XISION (753.9474) info@plexision.com


You are here


Plexision’s pipeline as based on two classes of patented or patent-pending, high-resolution cell-based test systems. These test systems detect respectively, the patient’s immune system’s inflammatory response to the pathogen or affinity to the pathogen.


  • The PleximarkTMCMV test measures cell-based immunity to the cytomegalovirus (CMV).
  • Infection with CMV occurs in individuals with immune systems, which have been weakened by disease and drug therapy.
  • During CMV infection, immunity to CMV decreases. Successful treatment restores immunity to CMV.
  • Knowledge about immunity to CMV can help the healthcare provider determine when to start, stop or continue drug therapy for CMV.